Abstract
Sixteen patients in whom schizophrenia was initially diagnosed and who were treated with fluphenazine enanthate or decanoate developed severe depression for a short period after the injection. In five cases this depression is thought to have been responsible for suicide. In 8 out of 10 cases the depression responded to electroplexy (E.C.T.). It is recommended that patients who are treated with fluphenazine should be carefully supervised. © 1969, British Medical Journal Publishing Group. All rights reserved.
Cite
CITATION STYLE
de Alarcon, R., & Carney, M. W. P. (1969). Severe Depressive Mood Changes Following Slow-release Intramuscular Fluphenazine Injection. British Medical Journal, 3(5670), 564–567. https://doi.org/10.1136/bmj.3.5670.564
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.